镁钾复合物纠正COVID-19患儿健康状况的有效性评价

Q4 Medicine
Y. Marushko, O.A. Dmytryshyn
{"title":"镁钾复合物纠正COVID-19患儿健康状况的有效性评价","authors":"Y. Marushko, O.A. Dmytryshyn","doi":"10.15574/sp.2023.132.7","DOIUrl":null,"url":null,"abstract":"The health status of children and adolescents after an acute episode of COVID-19, namely the post-acute and long-term consequences of SARS-CoV-2, is an urgent medical problem. The pathogenesis of the development of the post-covid state has not yet been fully studied and includes various links, including a violation of the constancy of the levels of various macroelements in biological tissues and blood. Since the leading role in ensuring the proper functioning of energy and synthetic processes in the body belongs to magnesium, it is assumed that the development of post-covid state may be associated with hypomagnesemia. Purpose - to evaluate the level of magnesium in the blood serum of children who have suffered from COVID-19, to analyze their state of health, level of tolerance to physical exertion, and quality of life; to optimize approaches to the correction of detected violations, by prescribing a magnesium-potassium complex, and to evaluate its effectiveness. Materials and methods. 75 children aged 6 to 18 took part in the study. Among them, 60 children with a confirmed diagnosis of COVID-19 in the anamnesis and a period after COVID-19 more than 12 weeks and 15 somatically healthy children of the same age did not suffer from COVID-19 (control group). Children with COVID-19 were divided into a main group (35 children who had reduced serum magnesium levels) and a control group (25 children with normal magnesium levels). The research was conducted in two stages. In the first stage, the health status of children who suffered from COVID-19 was analyzed. The second stage of the study involved the appointment of PANCICOR magnesium-potassium complex to children of the main group and the evaluation of the effectiveness of its use on the 60th day of treatment. General clinical (analysis of anamnesis data, Rufier test results, questionnaire), laboratory (determination of magnesium level in blood serum), instrumental (cycle ergometry), and statistical research methods were used. Results. Magnesium deficiency is a common disorder of macronutrient homeostasis in children who have experienced COVID-19. Post- covid syndrome was detected in 28.3% of children. At the same time, the proportion of post-covid state detection was higher in the group of children with magnesium deficiency compared to the group of children with normal serum magnesium levels. The level of tolerance to physical exertion and indicators of quality of life in children who suffered from COVID-19 are significantly lower (p<0.05) compared to children in the control group who did not suffer from COVID-19. The analysis of the parameters of the health status of children on the 60th day of taking the magnesium-potassium complex PANCICOR showed a positive effect of the drug on the characteristics of the state of health that were studied. In particular, on the 30th day of treatment, no child noted the manifestations of the post-covid condition. Indicators of the quality of life and tolerance to physical exertion statistically significantly increased and improved (p=0.002 and p=0.005, respectively) compared with the results at the initial visit. Conclusions. The use of the magnesium-potassium complex allows you to influence the basic links of the pathogenesis of the post-covid state and the consequences of the transferred COVID-19 associated with magnesium deficiency, as well as to promote the restoration of the adaptive reserves of the body after an acute episode of COVID-19. The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of the institution mentioned in the work. Informed consent from the children’s parents was obtained for the research. No conflict of interests was declared by the authors.","PeriodicalId":34724,"journal":{"name":"Suchasna pediatriia Ukrayina","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of the effectiveness of the magnesium-potassium complex in correcting the health status of children who have suffered from COVID-19\",\"authors\":\"Y. Marushko, O.A. Dmytryshyn\",\"doi\":\"10.15574/sp.2023.132.7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The health status of children and adolescents after an acute episode of COVID-19, namely the post-acute and long-term consequences of SARS-CoV-2, is an urgent medical problem. The pathogenesis of the development of the post-covid state has not yet been fully studied and includes various links, including a violation of the constancy of the levels of various macroelements in biological tissues and blood. Since the leading role in ensuring the proper functioning of energy and synthetic processes in the body belongs to magnesium, it is assumed that the development of post-covid state may be associated with hypomagnesemia. Purpose - to evaluate the level of magnesium in the blood serum of children who have suffered from COVID-19, to analyze their state of health, level of tolerance to physical exertion, and quality of life; to optimize approaches to the correction of detected violations, by prescribing a magnesium-potassium complex, and to evaluate its effectiveness. Materials and methods. 75 children aged 6 to 18 took part in the study. Among them, 60 children with a confirmed diagnosis of COVID-19 in the anamnesis and a period after COVID-19 more than 12 weeks and 15 somatically healthy children of the same age did not suffer from COVID-19 (control group). Children with COVID-19 were divided into a main group (35 children who had reduced serum magnesium levels) and a control group (25 children with normal magnesium levels). The research was conducted in two stages. In the first stage, the health status of children who suffered from COVID-19 was analyzed. The second stage of the study involved the appointment of PANCICOR magnesium-potassium complex to children of the main group and the evaluation of the effectiveness of its use on the 60th day of treatment. General clinical (analysis of anamnesis data, Rufier test results, questionnaire), laboratory (determination of magnesium level in blood serum), instrumental (cycle ergometry), and statistical research methods were used. Results. Magnesium deficiency is a common disorder of macronutrient homeostasis in children who have experienced COVID-19. Post- covid syndrome was detected in 28.3% of children. At the same time, the proportion of post-covid state detection was higher in the group of children with magnesium deficiency compared to the group of children with normal serum magnesium levels. The level of tolerance to physical exertion and indicators of quality of life in children who suffered from COVID-19 are significantly lower (p<0.05) compared to children in the control group who did not suffer from COVID-19. The analysis of the parameters of the health status of children on the 60th day of taking the magnesium-potassium complex PANCICOR showed a positive effect of the drug on the characteristics of the state of health that were studied. In particular, on the 30th day of treatment, no child noted the manifestations of the post-covid condition. Indicators of the quality of life and tolerance to physical exertion statistically significantly increased and improved (p=0.002 and p=0.005, respectively) compared with the results at the initial visit. Conclusions. The use of the magnesium-potassium complex allows you to influence the basic links of the pathogenesis of the post-covid state and the consequences of the transferred COVID-19 associated with magnesium deficiency, as well as to promote the restoration of the adaptive reserves of the body after an acute episode of COVID-19. The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of the institution mentioned in the work. Informed consent from the children’s parents was obtained for the research. No conflict of interests was declared by the authors.\",\"PeriodicalId\":34724,\"journal\":{\"name\":\"Suchasna pediatriia Ukrayina\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Suchasna pediatriia Ukrayina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15574/sp.2023.132.7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Suchasna pediatriia Ukrayina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15574/sp.2023.132.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

COVID-19急性发作后儿童和青少年的健康状况,即SARS-CoV-2急性后和长期后果,是一个紧迫的医学问题。新冠肺炎后状态的发病机制尚未得到充分研究,涉及多个环节,包括破坏生物组织和血液中各种常量元素水平的稳定性。由于镁在确保体内能量和合成过程的正常运作中起主导作用,因此假设新冠肺炎后状态的发展可能与低镁血症有关。目的——评估COVID-19患儿血清镁水平,分析其健康状况、体力消耗耐受性和生活质量;通过处方镁钾配合物来优化纠正检测到的违规行为的方法,并评估其有效性。材料和方法。75名6至18岁的儿童参加了这项研究。其中,60名在失忆期及发病后12周以上确诊为COVID-19的儿童和15名身体健康的同龄儿童未患COVID-19(对照组)。将感染COVID-19的儿童分为主组(35名血清镁水平降低的儿童)和对照组(25名镁水平正常的儿童)。研究分两个阶段进行。第一阶段对新冠肺炎患儿健康状况进行分析。研究的第二阶段包括对主要组儿童使用PANCICOR镁钾复合物,并在治疗的第60天评估其使用的有效性。采用一般临床(分析记忆资料、Rufier试验结果、问卷调查)、实验室(测定血清镁水平)、仪器(周期测量法)和统计学研究方法。结果。镁缺乏症是感染COVID-19的儿童常见的常量营养素体内平衡紊乱。28.3%的儿童检测到新冠肺炎后综合征。与此同时,镁缺乏儿童组的新冠后状态检测比例高于血清镁水平正常儿童组。与未感染COVID-19的对照组儿童相比,感染COVID-19的儿童体力消耗耐受性水平和生活质量指标显著降低(p<0.05)。对服用镁钾复合物panicor第60天儿童健康状况参数的分析表明,该药物对所研究的健康状态特征有积极的影响。特别是,在治疗的第30天,没有儿童注意到新冠肺炎后症状的表现。与初访结果相比,患者的生活质量和体力消耗耐受性指标均有统计学意义上的提高和改善(p=0.002和p=0.005)。结论。使用镁钾复合物可以影响COVID-19后状态发病机制的基本环节,以及与缺镁相关的转移性COVID-19的后果,并促进COVID-19急性发作后身体适应性储备的恢复。这项研究是按照《赫尔辛基宣言》的原则进行的。研究方案经工作中提到的机构当地伦理委员会批准。本研究获得了儿童父母的知情同意。作者未声明存在利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluation of the effectiveness of the magnesium-potassium complex in correcting the health status of children who have suffered from COVID-19
The health status of children and adolescents after an acute episode of COVID-19, namely the post-acute and long-term consequences of SARS-CoV-2, is an urgent medical problem. The pathogenesis of the development of the post-covid state has not yet been fully studied and includes various links, including a violation of the constancy of the levels of various macroelements in biological tissues and blood. Since the leading role in ensuring the proper functioning of energy and synthetic processes in the body belongs to magnesium, it is assumed that the development of post-covid state may be associated with hypomagnesemia. Purpose - to evaluate the level of magnesium in the blood serum of children who have suffered from COVID-19, to analyze their state of health, level of tolerance to physical exertion, and quality of life; to optimize approaches to the correction of detected violations, by prescribing a magnesium-potassium complex, and to evaluate its effectiveness. Materials and methods. 75 children aged 6 to 18 took part in the study. Among them, 60 children with a confirmed diagnosis of COVID-19 in the anamnesis and a period after COVID-19 more than 12 weeks and 15 somatically healthy children of the same age did not suffer from COVID-19 (control group). Children with COVID-19 were divided into a main group (35 children who had reduced serum magnesium levels) and a control group (25 children with normal magnesium levels). The research was conducted in two stages. In the first stage, the health status of children who suffered from COVID-19 was analyzed. The second stage of the study involved the appointment of PANCICOR magnesium-potassium complex to children of the main group and the evaluation of the effectiveness of its use on the 60th day of treatment. General clinical (analysis of anamnesis data, Rufier test results, questionnaire), laboratory (determination of magnesium level in blood serum), instrumental (cycle ergometry), and statistical research methods were used. Results. Magnesium deficiency is a common disorder of macronutrient homeostasis in children who have experienced COVID-19. Post- covid syndrome was detected in 28.3% of children. At the same time, the proportion of post-covid state detection was higher in the group of children with magnesium deficiency compared to the group of children with normal serum magnesium levels. The level of tolerance to physical exertion and indicators of quality of life in children who suffered from COVID-19 are significantly lower (p<0.05) compared to children in the control group who did not suffer from COVID-19. The analysis of the parameters of the health status of children on the 60th day of taking the magnesium-potassium complex PANCICOR showed a positive effect of the drug on the characteristics of the state of health that were studied. In particular, on the 30th day of treatment, no child noted the manifestations of the post-covid condition. Indicators of the quality of life and tolerance to physical exertion statistically significantly increased and improved (p=0.002 and p=0.005, respectively) compared with the results at the initial visit. Conclusions. The use of the magnesium-potassium complex allows you to influence the basic links of the pathogenesis of the post-covid state and the consequences of the transferred COVID-19 associated with magnesium deficiency, as well as to promote the restoration of the adaptive reserves of the body after an acute episode of COVID-19. The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of the institution mentioned in the work. Informed consent from the children’s parents was obtained for the research. No conflict of interests was declared by the authors.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Suchasna pediatriia Ukrayina
Suchasna pediatriia Ukrayina Medicine-Pediatrics, Perinatology and Child Health
CiteScore
0.40
自引率
0.00%
发文量
50
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信